New glutathione formula shows promise in small study
NCT ID NCT06345950
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new micellar form of the antioxidant glutathione in 16 healthy adults. Researchers compared how well it was absorbed versus standard and liposomal glutathione capsules over 30 days. The goal was to see if the new formulation leads to higher levels in the blood and is safe to take.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- glutathione (dietary supplement)
- What this could lead to
- If successful, this could lead to a more effective glutathione supplement for general health support.
- What could go wrong
- This is a very small, early-stage study in healthy volunteers, so results may not apply to people with health conditions. The supplement is not a treatment for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOAVAILABILITY HEATHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ISURA
Burnaby, British Columbia, V2N 4S9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a two-drug combo better tame prostate trouble?
- New vaginal capsule aims to tackle stubborn bacterial vaginosis
- Tiny study checks if novel bacterium is safe for people
- New painkiller oliceridine tested against morphine in back surgery patients
- New online guide aids dementia caregivers in tough gun safety choices
- New supplement shows promise for stress and sleep in healthy adults